| Bioactivity | 5-Methoxycarbonylmethyl-2-thiouridine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 5-Methoxycarbonylmethyl-2-thiouridine |
| CAS | 20299-15-4 |
| Formula | C12H16N2O7S |
| Molar Mass | 332.33 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
5-Methoxycarbonylmethyl-2-thiouridine
CAS: 20299-15-4 F: C12H16N2O7S W: 332.33
5-Methoxycarbonylmethyl-2-thiouridine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor ac
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.